+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End Use (Medical Use, Recreational Use, Industrial Use), And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 90 Pages
  • July 2025
  • Region: Australia
  • Grand View Research
  • ID: 5450192
Description Jump to:

Australia Legal Cannabis Market Summary

The Australia legal cannabis market size was estimated at USD 123.9 million in 2024 and is projected to reach USD 815.1 million by 2033, growing at a CAGR of 20.3% from 2025 to 2033. The industry is driven by growing awareness of the health benefits of cannabis and the growing legalization of marijuana, mostly for medical purposes.

Furthermore, the increase in medical marijuana output as a result of increasing demand in the pharmaceutical sector is boosting overall growth. For instance, in 2016, the Australian Government legalized cannabis for medicinal purposes in all six states and two territories. Furthermore, the Therapeutic Goods Administration (TGA) regulates the supply of medicinal products in Australia.

In Australia, the legal framework regulating medicinal cannabis is constantly evolving and remains closely monitored. New legislation was enacted by the Australian government, allowing the Australian Capital Territory (ACT) to acquire and cultivate four plants per household for personal use. In October 2023, the Australian Capital Territory (ACT) introduced certain regulations on the use of products such as marijuana and hemp. It stated that individuals over 18 years old can own cannabis (fresh up to 150 grams or dried up to 50 grams). This factor is expected to contribute to their usage in Australia.

Moreover, as per the March 2025 updates, the tax benefit of recreational products in Australia is expected to reach USD 700 million annually, which is aimed at having significant implications for the industry. This figure, highlighted by the Australian Greens as they renew their pledge to advocate for legalizing recreational cannabis, underscores both the economic potential and the shifting political landscape surrounding cannabis legislation in Australia. The estimated USD 700 million revenue can be allocated to various public services, including healthcare, education, and infrastructure. By legalization, governments can create a new stream of income that can help alleviate budgetary pressures.

Australia Legal Cannabis Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the Australia legal cannabis market report based on sources, derivatives, and end use:

Sources Outlook (Revenue, USD Million, 2021 - 2033)

  • Marijuana
  • Flower
  • Oil and Tinctures
  • Hemp
  • Hemp CBD
  • Supplements
  • Industrial Hemp

Derivatives Outlook (Revenue, USD Million, 2021 - 2033)

  • CBD
  • THC
  • Others

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical
  • Cancer
  • Chronic Pain
  • Depression and Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer
  • Post Traumatic Stress Disorder (PTSD)
  • Parkinson's Disease
  • Tourette
  • Others
  • Recreational
  • Industrial

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Sources outlook
2.2.2. Derivatives outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. Australia Legal Cannabis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Parent Market Outlook
3.3. Ancillary Market Outlook
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.5. Australia Legal Cannabis Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.6. Market Trends in the Country
3.6.1. Introduction of New Cannabis Products
3.6.2. Celebrity Cannabis Engagement
3.6.3. Growing Popularity of Craft and Boutique Cannabis Brands
3.6.4. Improved Cannabis Cultivation and Distribution Technology
3.6.5. Federal and State Cannabis Policy Opportunities
3.7. Regulatory Scenario in Australia
3.8. Jurisdiction Analysis in Australia
3.9. Cannabis Consumption Pattern Analysis, Australia
3.10. Legal Cannabis Potential Trade Opportunity, Australia
3.10.1. Global Legal Marijuana Trade Route
3.10.2. Global Hemp Trade Route
3.11. Legal Cannabis Seed to Shelf Story
3.11.1. Section Description
3.11.2. Cultivators & Growers
3.11.3. Manufacturers & Producers
3.11.4. Testers
3.11.5. Wholesalers & Distributors
3.11.6. Retailers
3.11.7. Supply Chain Analysis
3.11.8. Supply Chain Network from Hemp Cultivators to CBD Consumer Products
3.11.9. Supply Chain Network of Hemp Biomass to Industrial Applications
3.11.10. Supply Chain Network from Marijuana Plants to Marijuana Oil
3.12. Profit Margin Analysis
Chapter 4. Australia Legal Cannabis Market: Sources, Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Sources Segment Dashboard
4.3. Global Australia Legal Cannabis Market by Sources, 2021 to 2033
4.4. Marijuana
4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.4.2. Flower
4.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.4.3. Oil and Tinctures
4.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.5. Hemp
4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.5.2. Hemp CBD
4.5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.5.3. Supplements
4.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
4.5.4. Industrial Hemp
4.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 5. Australia Legal Cannabis Market: Derivatives Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Derivatives Segment Dashboard
5.3. Global Australia Legal Cannabis Market by Derivatives, 2021 to 2033
5.4. CBD
5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.5. THC
5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. Australia Legal Cannabis Market: End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. End Use Segment Dashboard
6.3. Australia Legal Cannabis Market by End Use, 2021 to 2033
6.4. Medical
6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.2. Cancer
6.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.3. Chronic Pain
6.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.4. Depression and Anxiety
6.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.5. Arthritis
6.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.6. Diabetes
6.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.7. Glaucoma
6.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.8. Migraines
6.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.9. Epilepsy
6.4.9.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.10. Multiple Sclerosis
6.4.10.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.11. AIDS
6.4.11.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.12. Amyotrophic Lateral Sclerosis
6.4.12.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.13. Alzheimer
6.4.13.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.14. Post Traumatic Stress Disorder (PTSD)
6.4.14.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.15. Parkinson's Disease
6.4.15.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.16. Tourette
6.4.16.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.4.17. Others
6.4.17.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.5. Recreational
6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
6.6. Industrial
6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Market Position Analysis
7.4. Company Profiles
7.4.1. Cann Group Limited
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Zelira Therapeutics
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. AusCann Group Holdings Ltd.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Bod Australia
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Althea Group
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. ECOFIBRE
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Botanix Pharmaceuticals
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. EPSILON
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Little Green Pharma
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Incannex
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Australia legal cannabis market, by source, 2021 - 2033 (USD Million)
Table 4 Australia legal cannabis market, by derivatives, 2021 - 2033 (USD Million)
Table 5 Australia legal cannabis market, by end use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Australia legal cannabis market: market outlook
Fig. 8 Australia legal cannabis competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Australia legal cannabis market driver impact
Fig. 14 Australia legal cannabis market restraint impact
Fig. 15 Porter’s Analysis
Fig. 16 PESTLE Analysis
Fig. 17 Australia legal cannabis market: Sources movement analysis
Fig. 18 Australia legal cannabis market: Sources outlook and key takeaways
Fig. 19 Marijuana market estimates and forecast, 2021 - 2033
Fig. 20 Flower market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Oil & tinctures market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Hemp market estimates and forecast, 2021 - 2033
Fig. 23 Hemp CBD market estimates and forecast, 2021 - 2033
Fig. 24 Supplements market estimates and forecast, 2021 - 2033
Fig. 25 Industrial hemp market estimates and forecast, 2021 - 2033
Fig. 26 Australia legal cannabis market: Derivatives movement analysis
Fig. 27 Australia legal cannabis market: Derivatives outlook and key takeaways
Fig. 28 CBD market estimates and forecast, 2021 - 2033
Fig. 29 THC market estimates and forecast, 2021 - 2033
Fig. 30 Others market estimates and forecast, 2021 - 2033
Fig. 31 Australia legal cannabis market: Derivatives movement analysis
Fig. 32 Australia legal cannabis market: Derivatives outlook and key takeaways
Fig. 33 Medical market estimates and forecast, 2021 - 2033
Fig. 34 Cancer market estimates and forecast, 2021 - 2033
Fig. 35 Chronic Pain market estimates and forecast, 2021 - 2033
Fig. 36 Depression and Anxiety market estimates and forecast, 2021 - 2033
Fig. 37 Arthritis market estimates and forecast, 2021 - 2033
Fig. 38 Diabetes market estimates and forecast, 2021 - 2033
Fig. 39 Glaucoma market estimates and forecast, 2021 - 2033
Fig. 40 Migraines market estimates and forecast, 2021 - 2033
Fig. 41 Epilepsy market estimates and forecast, 2021 - 2033
Fig. 42 Multiple Sclerosis market estimates and forecast, 2021 - 2033
Fig. 43 AIDS market estimates and forecast, 2021 - 2033
Fig. 44 Amyotrophic Lateral Sclerosis market estimates and forecast, 2021 - 2033
Fig. 45 Alzheimer market estimates and forecast, 2021 - 2033
Fig. 46 Post Traumatic Stress Disorder (PTSD) market estimates and forecast, 2021 - 2033
Fig. 47 Parkinson's Disease market estimates and forecast, 2021 - 2033
Fig. 48 Tourette market estimates and forecast, 2021 - 2033
Fig. 49 Others market estimates and forecast, 2021 - 2033
Fig. 50 Recreational market estimates and forecast, 2021 - 2033
Fig. 51 Industrial market estimates and forecast, 2021 - 2033
Fig. 52 Key company categorization
Fig. 53 Heat map analysis, 2024

Companies Mentioned

  • Cann Group Limited
  • Zelira Therapeutics
  • AusCann Group Holdings Ltd.
  • Bod Australia
  • Althea Group
  • ECOFIBRE
  • Botanix Pharmaceuticals
  • EPSILON
  • Little Green Pharma
  • Incannex

Table Information

Report AttributeDetails
No. of Pages90
PublishedJuly 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 123.9 Million
Forecasted Market Value ( USD ) by 2033 $ 815.1 Million
Compound Annual Growth Rate20.3%
Regions CoveredAustralia
No. of Companies Mentioned10

Related Topics

Related Reports

Thailand Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC), Cultivation, End Use (Industrial Use, Recreational Use) with Growth Forecasts, 2025-2030 - Product Image

Thailand Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC), Cultivation, End Use (Industrial Use, Recreational Use) with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Thailand
From
Australia Legal Cannabis Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Australia Legal Cannabis Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 84 Pages
  • Australia
From
Cannabis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Cannabis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Legal Cannabis Market 2025-2029 - Product Image

Legal Cannabis Market 2025-2029

  • Report
  • 211 Pages
  • Global
From
Australia Legal Cannabis Market Report and Forecast 2025-2034 - Product Image

Australia Legal Cannabis Market Report and Forecast 2025-2034

  • Report
  • 142 Pages
  • Australia
From

About the Cannabis Market

The Cannabis market within the context of Analgesics is a rapidly growing industry. Cannabis-based products are increasingly being used as an alternative to traditional pharmaceuticals for the treatment of chronic pain. Cannabis-based products are believed to be more effective than traditional pharmaceuticals in providing relief from pain, inflammation, and other symptoms associated with chronic pain. Cannabis-based products are available in a variety of forms, including oils, tinctures, edibles, and topical creams. These products are often used in combination with traditional pharmaceuticals to provide relief from chronic pain. The Cannabis market is also being used to treat a variety of other conditions, including anxiety, depression, and insomnia. Cannabis-based products are believed to be more effective than traditional pharmaceuticals in providing relief from these conditions. The Cannabis market is also being used to treat a variety of other conditions, including anxiety, depression, and insomnia. Cannabis-based products are believed to be more effective than traditional pharmaceuticals in providing relief from these conditions. Companies in the Cannabis market include Canopy Growth Corporation, Aurora Cannabis, Tilray, and Cronos Group. These companies are involved in the production, distribution, and sale of cannabis-based products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.